by Justin Jackson , Medical Xpress Credit: Unsplash/CC0 Public Domain A collaboration of researchers led by Emory University Rollins School of Public Health, Atlanta, is urging caution when prescribing off-label glucose-lowering drugs to individuals with type 1 diabetes (T1D). Both glucagon-like peptide-1 receptor agonists (GLP-1RA) and sodium-glucose cotransporter 2 (SGLT2) inhibitors have shown significant benefits...
Tag: <span>off-label drugs</span>
Post
Off-label drugs prescribed for breathlessness may do more harm than good, warn scientists
September 9, 2024 by King’s College London A new study from King’s College London shows that off-label prescriptions of a common antidepressant doesn’t help breathlessness in patients with respiratory disease—and may cause side effects. Researchers warn prescribing medicines for a use which it has not been licensed could make things worse, even though the prescriber...
Post
New study examines off-label drugs prescribed in addition to insulin for type 1 diabetes
by UT Southwestern Medical Center Credit: Pixabay/CC0 Public Domain Two classes of drugs prescribed off-label for some patients with type 1 diabetes can provide significant benefits, but also come with health concerns, according to a study by UT Southwestern Medical Center researchers. The findings, published in The Journal of Clinical Endocrinology & Metabolism, provide a rare view...